Clinical Trials Browser

Phase 2 × Breast Neoplasms × Standard of Care × Clear all

NCT04567420 2026-06-03

DARE

Phase 2 Recruiting

Breast Neoplasms

NCT01042379 2026-05-06

I-SPY

Phase 2 Recruiting

Pathologic Complete Response, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Triple Negative Breast Neoplasms

NCT03808337 2026-02-27

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

Phase 2 Recruiting

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Triple Negative Breast Neoplasms

NCT00929214 2025-12-17

Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients

Phase 2 Active not recruiting

Breast Neoplasms, Neoplasm Metastasis

NCT01723774 2025-12-09

PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer

Phase 2 Active not recruiting

84 enrolled 17 charts

Breast Neoplasms

NCT02101385 2023-09-28

Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer

Phase 2 Completed

193 enrolled 21 charts

Breast Neoplasms

NCT02950480 2019-10-01

Breast Capsular Contracture Following Post-Mastectomy Reconstruction in Women Treated With the Leukotriene Inhibitor Zafirlukast: A Phase II Trial

Phase 2 Terminated

4 enrolled 8 charts

Breast Neoplasms

NCT00977379 2016-11-15

XERAD

Phase 2 Terminated

24 enrolled 20 charts

Breast Neoplasms